Rasburicase and tumor lysis syndrome: lower dosage, consideration of indications, and hyperhydration

J Clin Oncol. 2011 Jan 20;29(3):e67-8; author reply e69. doi: 10.1200/JCO.2010.32.6751. Epub 2010 Dec 13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Child
  • Dose-Response Relationship, Drug
  • Drug Costs
  • Gout Suppressants / administration & dosage
  • Gout Suppressants / economics
  • Gout Suppressants / therapeutic use*
  • Humans
  • Hyperphosphatemia / prevention & control
  • Hyperuricemia / drug therapy*
  • Tumor Lysis Syndrome / prevention & control*
  • Urate Oxidase / administration & dosage
  • Urate Oxidase / economics
  • Urate Oxidase / therapeutic use*

Substances

  • Gout Suppressants
  • rasburicase
  • Urate Oxidase